Cardiac biomarkers levels predict pulmonary embolism extent on chest computed tomography and prognosis in non-massive pulmonary embolism.
Vuilleumier
Nicolas
N
Perrier
Arnaud
A
Sanchez
Jean-Charles
JC
Turck
Natacha
N
Le Gal
Grégoire
G
Verschuren
Frank
F
Gruson
Damien
D
Mensi
Noury
N
Hochstrasser
Denis
D
Righini
Marc
M
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects; D015415:Biomarkers; D002637:Chest Pain; D018450:Disease Progression; D004417:Dyspnea; D005260:Female; D005500:Follow-Up Studies; D006470:Hemorrhage / Q000139:chemically induced / Q000517:prevention & control; D006801:Humans; D008297:Male; D008875:Middle Aged; D009206:Myocardium / Q000378:metabolism*; D011379:Prognosis; D011655:Pulmonary Embolism / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D020246:Venous Thrombosis / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology
D000925:Anticoagulants; D015415:Biomarkers